Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer

NCT04083365 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

RECTAL CANCER

Interventions

DRUG: Capecitabine
DRUG: Radiotherapy
DRUG: Durvalumab

Sponsor

AUSL Romagna Rimini

Collaborators

[object Object]
[object Object]